http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2213546-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1a15aaad844e8195d1bee2b83e483db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bfdeb68a360fb8cf264f4cb4e4dc9c0
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2000-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2003-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcf577993c711a9f4c969afcc2ca800e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4446d7359164ac00f42fbd1b67e7f0e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f636ebc80ade29381d51c3801eac42a
publicationDate 2003-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2213546-C2
titleOfInvention Method for treating progressing myopia in children
abstract FIELD: medicine, ophthalmology. SUBSTANCE: one should carry out sclera-strengthening operation, catheterization of Tenon's space is conducted, fractionally neurotrophic preparations are injected by combining such injection with synchronous magnetic and chromatic stimulation at delay of magnetic impulse against chromatic one and, also, the course of exercises directed to train accommodation and study cyclically moving symbols at their constant angular size. The present innovation enables to decrease myopia progressing in children due to complex impact upon different links of disease pathogenesis. EFFECT: higher efficiency of therapy. 2 ex
priorityDate 2000-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407866699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4740

Total number of triples: 18.